Absci (ABSI) Other Operating Expenses (2020 - 2026)
Absci (ABSI) posted Other Operating Expenses of $2.7 million for Q1 2026, up 220.02% sequentially from -$2.3 million in Q4 2025, and down 11.2% YoY from $3.1 million in Q1 2025.
Absci (ABSI) Other Operating Expenses (2020 - 2026) Analysis & Trends
Absci has reported Other Operating Expenses for 7 years, with the latest figure at $2.7 million in Q1 2026.
- Quarterly Other Operating Expenses fell 11.2% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 51.73% YoY) and the FY2025 annual result came in at $6.6 million, down 50.4% from the prior year.
- Other Operating Expenses improved to $2.7 million in Q1 2026 per ABSI's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $24.8 million in Q2 2023 and troughed at -$2.3 million in Q4 2025.
- A 5-year average of $4.2 million and a median of $3.4 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses soared 690.61% in 2023, then slumped 170.28% in 2025.
- Over 5 years, Other Operating Expenses stood at $3.6 million in 2022, then slipped by 2.84% to $3.5 million in 2023, then dropped by 7.18% to $3.2 million in 2024, then plunged by 170.28% to -$2.3 million in 2025, then jumped by 220.02% to $2.7 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $2.7 million, -$2.3 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | -2.27 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 24.83 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 3.59 Mn |
| Sep 30, 2022 | 3.40 Mn |
| Jun 30, 2022 | 3.14 Mn |
| Mar 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2.76 Mn |
| Sep 30, 2021 | 2.22 Mn |